arrow
J

Jane A. O'Halloran

Washington University School of Medicine
H指数:36
被引数:6,882

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characterizing Host Inflammatory Bioprofiles in People With Postacute Sequelae SARS-CoV-2 Infection (PASC)

表征SARS-CoV-2感染后急性期后遗症(PASC)人群宿主炎症生物特征

2026-09-300
OAAI
Germinal center–mediated broadening of B cell responses to SARS-CoV-2 booster immunization

生发中心介导的B细胞对SARS-CoV-2加强免疫应答的广化

2025-10-100
PRE
Antibody Responses are Sustained 2 Years Post-Mpox Infection but not Following Modified Vaccinia Ankara-Bavarian Nordic Vaccination

抗体反应在 Mpox 感染后2年得以维持,但在 Modified Vaccinia Ankara-Bavarian Nordic 疫苗接种后并未出现。

2025-09-010
OAAI
Specific thresholds of circulating antibody titers predict against infection and reduced disease severity in SARS-CoV-2 close contacts

循环抗体滴度的特定阈值可预测SARS-CoV-2密切接触者的感染风险及疾病严重程度降低。

2025-05-220
OA
Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infection

SARS-CoV-2疫苗后强大而持久的b细胞反应决定了对SARS-CoV-2感染的保护

2024-09-171
OAAI
CD4+ T cells exhibit distinct transcriptional phenotypes in the lymph nodes and blood following mRNA vaccination in humans
2024-08-201
OA
Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activity
2024-01-042
OA
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial

Abatacept,Cenicriviroc或英夫利昔单抗治疗COVID-19肺炎住院成人的随机临床试验

2023-07-2535
OA
SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients
2022-12-227
OAAI
Reactogenicity of the Messenger RNA SARS-CoV-2 Vaccines Associated With Immunogenicity in Patients With Autoimmune and Inflammatory Disease
2022-08-155
OA